Adjuvant comparison and characterization
Active Definitive Contract Awarded Last action
- Contract number
- 75N93022C00054
- Awardee
-
University Of California Irvine UEI MJC5FCYQTPE6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,983,474
Award facts
- Opportunity
-
- Adjuvant Comparison and Characterization Pre-Solicitation · BAADAIT75N93020R0002 · Posted Mar 10, 2021
- Contract value 100% obligated
- $12,983,474.00 Current and potential, with all options
- Completion date 74% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Irvine, CA 92617, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | $2,749,309 | |
| Change Order | $1,471,321 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $400,000 | |
| Change Order | $654,060 | |
| Exercise an Option | $1,721,004 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $500,000 | |
| Exercise an Option | $1,052,916 | |
| Exercise an Option | $1,703,088 | |
| Exercise an Option | $1,057,196 | |
| Original award | $1,674,580 |
Show all 15
About this award
The National Institute of Allergy and Infectious Diseases awarded a $12,983,474 definitive contract to University of California Irvine for adjuvant comparison and characterization on September 1, 2022, under cost-no-fee pricing with no set-aside.
The originating pre-solicitation, posted March 10, 2021, describes comparative immunological assessment of multiple adjuvants across vaccine and antigen platforms using comprehensive immune profiling, omics, and functional assays to establish immunological signatures of adjuvant strength, quality, breadth, and durability. The solicitation contemplated 3–5 awards totaling approximately $7.5 million, with $5.5 million allocated to non-HIV vaccines and up to $2 million for projects including HIV antigens. Place of performance is Irvine, CA.
The contract runs through April 30, 2028. Service Contract Inventory reporting shows FY2024 invoiced labor of $2.8 million supporting 3.3 FTEs across 6,859 contractor hours, with a derived government-paid hourly rate of $409.15 per hour. FY2025 invoiced labor reached $2.2 million supporting 7.0 FTEs. University of California Irvine self-performed all reported hours with no subcontractors engaged.
Quick answers
Who was awarded contract 75N93022C00054?
75N93022C00054 was awarded to University Of California Irvine by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2022.
How much is contract 75N93022C00054 worth?
The government has obligated $12,983,474 on 75N93022C00054.
Was contract 75N93022C00054 competed?
The extent of competition for 75N93022C00054 was full and open competition. The government received 10 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award